| Title: |
A phase II trial of ipilimumab, nivolumab, or ipilimumab and nivolumab with or without azacitidine in relapsed or refractory myelodysplastic neoplasms |
| Authors: |
Bouligny, Ian M.Aff1; Montalban-Bravo, GuillermoAff1; Sasaki, KojiAff1; Daver, NavalAff1; Jabbour, EliasAff1; Alvarado, YesidAff1; DiNardo, Courtney D.Aff1; Ravandi, FarhadAff1; Borthakur, GautamAff1; Pemmaraju, NaveenAff1; Kadia, TapanAff1; Masarova, LuciaAff1; Takahashi, KoichiAff1; Andreeff, MichaelAff1; Bazinet, AlexandreAff1; Yang, HuiAff1; Kanagal, RashmiAff2; Pierce, SherryAff1; Meyer, MeghanAff1; Huang, XuelinAff3; Garcia-Manero, GuillermoAff1, IDs41375024024577_cor1 |
| Source: |
Leukemia. 39(2):524-528 |
| Database: |
Springer Nature Journals |